Table of Contents Global Cerebrovascular Disease Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 Cerebrovascular Disease Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Cerebrovascular Disease Segment by Type 1.2.1 Carotid Endarterectomy 1.2.2 Carotid Angioplasty Or Carotid Artery Stenting 1.2.3 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) 1.3 Market Analysis by Application 1.3.1 Academic & Research Institutes 1.3.2 Pharmaceutical & Biotechnology Companies 1.3.3 Hospitals & Diagnostic Centers 1.3.4 Contract Research Organizations 1.3.5 Others 1.4 Overview of Global Cerebrovascular Disease Market 1.4.1 Global Cerebrovascular Disease Revenue (2015-2025) 1.4.2 Global Cerebrovascular Disease Production and Capacity (2015-2025) 1.4.3 North America Cerebrovascular Disease Status and Prospect (2015-2025) 1.4.4 Europe Cerebrovascular Disease Status and Prospect (2015-2025) 1.4.5 Japan Cerebrovascular Disease Status and Prospect (2014-2025) 1.4.6 China Cerebrovascular Disease Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Cerebrovascular Disease Industry Impact 1.6.1 How the Covid-19 is Affecting the Cerebrovascular Disease Industry 1.6.2 Cerebrovascular Disease Business Impact Assessment - Covid-19 1.6.3 Market Trends and Cerebrovascular Disease Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Cerebrovascular Disease Market Competition by Manufacturer 2.1 Global Cerebrovascular Disease Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Cerebrovascular Disease Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Cerebrovascular Disease Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Cerebrovascular Disease Manufacturer Market Share 2.5 Top 10 Cerebrovascular Disease Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Cerebrovascular Disease Market 2.7 Key Manufacturers Cerebrovascular Disease Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Cerebrovascular Disease Industry Key Manufacturers 3.1 Johnson & Johnson 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Johnson & Johnson Cerebrovascular Disease Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Johnson & Johnson News 3.2 Amgen 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Amgen Cerebrovascular Disease Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Amgen News 3.3 GlaxoSmithKline 3.3.1 Company Details 3.3.2 Product Information 3.3.3 GlaxoSmithKline Cerebrovascular Disease Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 GlaxoSmithKline News 3.4 Sanofi-Aventis 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Sanofi-Aventis Cerebrovascular Disease Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Sanofi-Aventis News 3.5 Merck 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Merck Cerebrovascular Disease Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Merck News 3.6 Sangamo BioSciences 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Sangamo BioSciences Cerebrovascular Disease Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Sangamo BioSciences News 3.7 Aldagen 3.7.1 Company Details 3.7.2 Product Information 3.7.3 Aldagen Cerebrovascular Disease Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 Aldagen News 4 Global Cerebrovascular Disease Market Size Categorized by Regions (2015-2020) 4.1 Global Cerebrovascular Disease Sales Market Share by Region 4.2 Global Cerebrovascular Disease Revenue Market Share by Region (2015-2019) 4.3 Global Cerebrovascular Disease Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America Cerebrovascular Disease Market Size Detail 4.4.1 North America Cerebrovascular Disease Sales Growth Rate (2015-2020) 4.4.2 North America Cerebrovascular Disease Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe Cerebrovascular Disease Market Size Detail 4.5.1 Europe Cerebrovascular Disease Sales Growth Rate (2015-2020) 4.5.2 Europe Cerebrovascular Disease Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan Cerebrovascular Disease Market Size Detail 4.6.1 Japan Cerebrovascular Disease Sales Growth Rate (2015-2020) 4.6.2 Japan Cerebrovascular Disease Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China Cerebrovascular Disease Market Size Detail 4.7.1 China Cerebrovascular Disease Sales Growth Rate (2015-2020) 4.7.2 China Cerebrovascular Disease Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global Cerebrovascular Disease Market Segment by Type 5.1 Global Cerebrovascular Disease Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global Cerebrovascular Disease Sales and Market Share by Type (2015-2020) 5.1.2 Global Cerebrovascular Disease Revenue and Market Share by Type (2015-2020) 5.2 Carotid Endarterectomy Sales Growth Rate and Price 5.2.1 Global Carotid Endarterectomy Sales Growth Rate (2015-2020) 5.2.2 Global Carotid Endarterectomy Price (2015-2020) 5.3 Carotid Angioplasty Or Carotid Artery Stenting Sales Growth Rate and Price 5.3.1 Global Carotid Angioplasty Or Carotid Artery Stenting Sales Growth Rate (2015-2020) 5.3.2 Global Carotid Angioplasty Or Carotid Artery Stenting Price (2015-2020) 5.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Sales Growth Rate and Price 5.4.1 Global Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Sales Growth Rate (2015-2020) 5.4.2 Global Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Price (2015-2020) 6 Global Cerebrovascular Disease Market Segment by Application 6.1 Global Cerebrovascular Disease Sales Market Share by Application (2015-2020) 6.2 Academic & Research Institutes Sales Growth Rate (2015-2020) 6.3 Pharmaceutical & Biotechnology Companies Sales Growth Rate (2015-2020) 6.4 Hospitals & Diagnostic Centers Sales Growth Rate (2015-2020) 6.5 Contract Research Organizations Sales Growth Rate (2015-2020) 6.6 Others Sales Growth Rate (2015-2020) 7 Cerebrovascular Disease Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 Cerebrovascular Disease Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global Cerebrovascular Disease Market Forecast 8.1 Global Cerebrovascular Disease Sales, Revenue Forecast 8.1.1 Global Cerebrovascular Disease Sales Growth Rate Forecast (2020-2025) 8.1.2 Global Cerebrovascular Disease Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global Cerebrovascular Disease Price and Trend Forecast (2020-2025) 8.2 Global Cerebrovascular Disease Sales Forecast by Region (2020-2025) 8.2.1 North America Cerebrovascular Disease Sales, Revenue Forecast (2020-2025) 8.2.2 Europe Cerebrovascular Disease Sales, Revenue Forecast (2020-2025) 8.2.3 Japan Cerebrovascular Disease Production, Revenue Forecast (2020-2025) 8.2.4 China Cerebrovascular Disease Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure Cerebrovascular Disease Picture Table Global Cerebrovascular Disease Sales by Type Figure Global Sales Market Share of Cerebrovascular Disease by Product Type in 2019 Table Breakdown of Cerebrovascular Disease by Company Type (Tier 1, Tier 2 and Tier 3) Figure Cerebrovascular Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Carotid Endarterectomy Picture Figure Carotid Angioplasty Or Carotid Artery Stenting Picture Figure Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Picture Table Global Cerebrovascular Disease Sales by Application Figure Global Cerebrovascular Disease Sales Market Share by Application in 2019 Figure Academic & Research Institutes Picture Figure Pharmaceutical & Biotechnology Companies Picture Figure Hospitals & Diagnostic Centers Picture Figure Contract Research Organizations Picture Figure Others Picture Table Cerebrovascular Disease Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Cerebrovascular Disease Revenue (Million US$) (2015-2025) Figure Global Cerebrovascular Disease Production (K Units) (2015-2025) Figure North America Cerebrovascular Disease Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Cerebrovascular Disease Revenue (Million US$) Growth Rate (2015-2025) Figure Japan Cerebrovascular Disease Revenue (Million US$) Growth Rate (2014-2025) Figure China Cerebrovascular Disease Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Cerebrovascular Disease Sales by Manufacturer (2018-2020) Figure Global Cerebrovascular Disease Sales Market Share by Manufacturer in 2019 Table Global Cerebrovascular Disease Revenue by Manufacturer (2018-2020) Figure Global Cerebrovascular Disease Revenue Market Share by Manufacturer in 2019 Table Global Cerebrovascular Disease Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Cerebrovascular Disease Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Cerebrovascular Disease Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Cerebrovascular Disease Market Table Key Manufacturers Cerebrovascular Disease Product Type Table Mergers & Acquisitions Planning Table Johnson & Johnson Company Profile Figure Cerebrovascular Disease Product Picture and Specifications of Johnson & Johnson Table Cerebrovascular Disease Production, Price, Revenue and Gross Margin of 2018-2020 Figure Johnson & Johnson Cerebrovascular Disease Market Share (2018-2020) Table Johnson & Johnson Main Business Table Johnson & Johnson Recent Development Table Amgen Company Profile Figure Cerebrovascular Disease Product Picture and Specifications of Amgen Table Cerebrovascular Disease Production, Price, Revenue and Gross Margin of 2018-2020 Figure Amgen Cerebrovascular Disease Market Share (2018-2020) Table Amgen Main Business Table Amgen Recent Development Table GlaxoSmithKline Company Profile Figure Cerebrovascular Disease Product Picture and Specifications of GlaxoSmithKline Table Cerebrovascular Disease Production, Price, Revenue and Gross Margin of 2018-2020 Figure GlaxoSmithKline Cerebrovascular Disease Market Share (2018-2020) Table GlaxoSmithKline Main Business Table GlaxoSmithKline Recent Development Table Sanofi-Aventis Company Profile Figure Cerebrovascular Disease Product Picture and Specifications of Sanofi-Aventis Table Cerebrovascular Disease Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sanofi-Aventis Cerebrovascular Disease Market Share (2018-2020) Table Sanofi-Aventis Main Business Table Sanofi-Aventis Recent Development Table Merck Company Profile Figure Cerebrovascular Disease Product Picture and Specifications of Merck Table Cerebrovascular Disease Production, Price, Revenue and Gross Margin of 2018-2020 Figure Merck Cerebrovascular Disease Market Share (2018-2020) Table Merck Main Business Table Merck Recent Development Table Sangamo BioSciences Company Profile Figure Cerebrovascular Disease Product Picture and Specifications of Sangamo BioSciences Table Cerebrovascular Disease Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sangamo BioSciences Cerebrovascular Disease Market Share (2018-2020) Table Sangamo BioSciences Main Business Table Sangamo BioSciences Recent Development Table Aldagen Company Profile Figure Cerebrovascular Disease Product Picture and Specifications of Aldagen Table Cerebrovascular Disease Production, Price, Revenue and Gross Margin of 2018-2020 Figure Aldagen Cerebrovascular Disease Market Share (2018-2020) Table Aldagen Main Business Table Aldagen Recent Development Table Global Cerebrovascular Disease Sales (K Units) by Region (2015-2020) Table Global Cerebrovascular Disease Sales Market Share by Region (2015-2019) Figure Global Cerebrovascular Disease Sales Market Share by Region (2015-2019) Figure Global Cerebrovascular Disease Sales Market Share by Region in 2018 Table Global Cerebrovascular Disease Revenue (Million US$) by Region (2015-2020) Table Global Cerebrovascular Disease Revenue Market Share by Region (2015-2020) Figure Global Cerebrovascular Disease Revenue Market Share by Region (2015-2020) Figure Global Cerebrovascular Disease Revenue Market Share by Region in 2019 Table Global Cerebrovascular Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America Cerebrovascular Disease Sales (K Units) Growth Rate (2015-2020) Figure Europe Cerebrovascular Disease Sales (K Units) Growth Rate (2015-2020) Table Europe Cerebrovascular Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan Cerebrovascular Disease Sales (K Units) Growth Rate (2015-2020) Table Japan Cerebrovascular Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China Cerebrovascular Disease Sales (K Units) Growth Rate (2015-2020) Table China Cerebrovascular Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global Cerebrovascular Disease Sales by Type (2015-2020) Table Global Cerebrovascular Disease Sales Market Share by Type (2015-2020) Figure Global Cerebrovascular Disease Sales Market Share by Type in 2019 Table Global Cerebrovascular Disease Revenue by Type (2015-2020) Table Global Cerebrovascular Disease Revenue Market Share by Type (2015-2020) Figure Global Cerebrovascular Disease Revenue Market Share by Type in 2019 Figure Global Carotid Endarterectomy Sales Growth Rate (2015-2025) Figure Global Carotid Endarterectomy Price (2015-2020) Figure Global Carotid Angioplasty Or Carotid Artery Stenting Sales Growth Rate (2015-2025) Figure Global Carotid Angioplasty Or Carotid Artery Stenting Price (2015-2020) Figure Global Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Sales Growth Rate (2015-2025) Figure Global Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Price (2015-2020) Table Global Cerebrovascular Disease Sales Market Share by Application (2015-2020) Figure Global Cerebrovascular Disease Sales Market Share by Application in 2019 Figure Global Academic & Research Institutes Sales Growth Rate (2015-2025) Figure Global Pharmaceutical & Biotechnology Companies Sales Growth Rate (2015-2025) Figure Global Hospitals & Diagnostic Centers Sales Growth Rate (2015-2025) Figure Global Contract Research Organizations Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Cerebrovascular Disease Table Key Players of Downstream Markets Figure Sales Channel Figure Global Cerebrovascular Disease Production (K Units) Growth Rate Forecast (2020-2025) Figure Global Cerebrovascular Disease Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global Cerebrovascular Disease Price and Trend Forecast (2020-2025) Table Global Cerebrovascular Disease Sales (K Units) Forecast by Region (2020-2025) Figure Global Cerebrovascular Disease Production Market Share Forecast by Region (2020-2025) Figure North America Cerebrovascular Disease Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America Cerebrovascular Disease Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe Cerebrovascular Disease Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe Cerebrovascular Disease Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan Cerebrovascular Disease Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan Cerebrovascular Disease Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China Cerebrovascular Disease Production (K Units) Growth Rate Forecast (2020-2025) Figure China Cerebrovascular Disease Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Johnson & Johnson Amgen GlaxoSmithKline Sanofi-Aventis Merck